Dr. Su-Boon Yong is the Chief of Department of Pediatrics, Division of Allergy, Immunology and Rheumatology at Show Chwan Memorial Hospital, Taiwan, ROC. Dr. Yong received his medical degree from the National Cheng Kung Medical College University and now at PhD program at the Institute of Medicine, Chung Shan Medical College University, Taiwan, ROC. He completed his pediatrics residency at the Department of Pediatrics, Kao-Shiung Chang Gung Memorial Hospital, Taiwan, ROC. Dr. Yong continues to make contributions to the scientific community. His primary field of study is primary focus on the safety of biological therapy for autoimmune diseases, childhood rheumatology diseases and childhood asthma diseases. Dr. Yong has been invited to speak at international conferences and institutes. In 2018, he was a keynote speaker for Pediatrics Submit Conference in Tokyo, Japan and was also invited to speak at the DOHaD (Developmental Origins of Health and Disease) meeting in Taiwan. Dr. Yong has been the first or corresponding author on more than 8 published articles in the last 5 years, including SCI original papers and reviews. Dr. Yong was also invited to be a reviewer for numerous journals, such as PLOSone, IJRD, The Global Journal of Medical and Clinical Case Reports. In addition to research, Dr. Yong has also devoted a great deal of time to education. He teaches the staff of the Show Chwan Memorial Hospital and the Nursing department of Chung Tai University, Taiwan, R.O.C. In 2015, the Show Chwan Memorial Hospital awarded him the Faculty Excellence Award in Teaching. Dr. Yong received the best oral presentation in 2015 in Taiwan and Outstanding Abstract Award from the Asian Society for Pediatric Researc,2017 in Hong Kong. Dr. Yong believes that increased availability of research data can benefit both medical research and science education.
Dr Su-Boon Yong is now Chief of Department of Pediatrics, Division of Allergy, Immunology and Rheumatology at Show Chwan Memorial Hospital. Dr Yong had wide-ranging research interests with primary focus on the safety of biological therapy for autoimmune diseases, childhood rheumatology diseases, cow milk protein allergy and allergy sensitization